Based on our previous findings that SCGN is specifically highly expressed in tumor tissues in the early stages of ccRCC 16, it could be used as a marker for ccRCC diagnosis, but whether it is specifically present in ccRCC but not in other types of RCC deserves further investigation. Here, SCGN is linked to renal cell carcinoma.